Le Lézard
Classified in: Health
Subjects: WOM, AVO

Planned Parenthood of NYC Slams a Court's Irresponsible Decision to Allow Trump's "Gag Rule"


NEW YORK, June 20, 2019 /PRNewswire/ -- Today, a federal appeals court granted the Trump administration's damaging "gag rule" to take effect nationwide, despite multiple lawsuits from states challenging the Title X restrictions. This attack on Title X, the nation's only federal family planning program, strips Planned Parenthood, including Planned Parenthood of New York City (PPNYC), of vital funding used to provide affordable sexual and reproductive health care to thousands of New Yorkers.

The "gag rule" is designed to prevent patients from getting birth control or preventive care from sexual and reproductive health care providers like Planned Parenthood. The family planning restrictions also makes it illegal for health care providers to refer patients for safe, legal abortion.

Statement from Laura McQuade, President and CEO, Planned Parenthood of New York City:

"This cruel and unethical decision by the Court of Appeals is part of a calculated assault on the fundamental freedoms of Americans. The "gag rule" will hit vulnerable New Yorkers who struggle to make ends meet, and have difficulty accessing affordable preventive health care the hardest - women, communities of color, LGBTQ individuals, and those with low incomes. Planned Parenthood of New York City won't stand for it.  PPNYC will turn to every resource available to help us fund affordable, quality sexual and reproductive health care - for anyone who needs it. Our doors will remain open, because WE CARE - NO MATTER WHAT."

The 9th Circuit granted the request from the Trump-Pence administration to block the preliminary injunctions in California, Oregon, and Washington, which allows the "gag rule" to go into effect in all states besides Maryland. Four judges had previously blocked the rule, with two judges blocking it nationwide.

Every year, 300,000 people in New York State, including 150,000 in NYC, receive health care through the Title X program.  Planned Parenthood serves 52% of New York State's Title X patients.

Twenty-two NYC health care providers receive Title X funding, including Planned Parenthood of New York City, 10 NYC Health + Hospital sites, and other community-based providers.

Since 1916, Planned Parenthood of New York City (PPNYC) has been an advocate for and provider of sexual and reproductive health services and education for New Yorkers. Providing more than 100,000 patient visits annually, PPNYC's health care centers in Manhattan, Brooklyn, the Bronx, Queens and Staten Island offer sexual and reproductive health services, including gynecological care, birth control, cancer screening, pregnancy testing, abortion, testing and treatment for sexually transmitted infections, HIV prevention, testing and counseling, transgender hormone therapy and vasectomy. Through a threefold mission of clinical services, education, and advocacy, PPNYC brings better health and more fulfilling lives to each new generation of New Yorkers. As a voice for reproductive freedom, PPNYC supports legislation and policies to ensure that all New Yorkers will have access to the full range of reproductive health care services and information.

Contact: Jacquelyn Marrero, [email protected] or 212-274-7337

SOURCE Planned Parenthood of New York City


These press releases may also interest you

at 20:25
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:12
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...

at 19:29
Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy...

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...



News published on and distributed by: